Daiwa Securities Group’s ANI Pharmaceuticals ANIP Stock Holding History

Daiwa Securities Group’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-70	Closed	-$6K	–	1199
2025 Q4	$6K	Hold	70	–	–	﹤0.01%	1216
2025 Q3	$6K	Hold	70	–	–	﹤0.01%	1186
2025 Q2	$5K	Hold	70	–	–	﹤0.01%	1155
2025 Q1	$5K	Hold	70	–	–	﹤0.01%	1126
2024 Q4	$4K	Hold	70	–	–	﹤0.01%	1169
2024 Q3	$4K	Hold	70	–	–	﹤0.01%	1174
2024 Q2	$4K	Hold	70	–	–	﹤0.01%	1205
2024 Q1	$5K	Hold	70	–	–	﹤0.01%	1203
2023 Q4	$4K	Hold	70	–	–	﹤0.01%	1217
2023 Q3	$4K	Hold	70	–	–	﹤0.01%	1168
2023 Q2	$4K	Hold	70	–	–	﹤0.01%	1191
2023 Q1	$3K	Hold	70	–	–	﹤0.01%	1175
2022 Q4	$3K	Buy	+70	New	+$2.63K	﹤0.01%	1186
2021 Q4	–	Sell	-27	Closed	-$1K	–	1387
2021 Q3	$1K	Hold	27	–	–	﹤0.01%	1259
2021 Q2	$1K	Hold	27	–	–	﹤0.01%	1178
2021 Q1	$1K	Hold	27	–	–	﹤0.01%	1185
2020 Q4	$1K	Sell	27 -41	-60%	-$1.17K	﹤0.01%	1162
2020 Q3	$2K	Hold	68	–	–	﹤0.01%	1136
2020 Q2	$3K	Hold	68	–	–	﹤0.01%	1134
2020 Q1	$3K	Hold	68	–	–	﹤0.01%	1131
2019 Q4	$4K	Sell	68 -8	-11%	-$530	﹤0.01%	1120
2019 Q3	$6K	Hold	76	–	–	﹤0.01%	1063
2019 Q2	$6K	Buy	76 +12	+19%	+$853	﹤0.01%	1080
2019 Q1	$5K	Hold	64	–	–	﹤0.01%	1079
2018 Q4	$3K	Hold	64	–	–	﹤0.01%	1085
2018 Q3	$4K	Hold	64	–	–	﹤0.01%	1089
2018 Q2	$4K	Hold	64	–	–	﹤0.01%	1105
2018 Q1	$4K	Buy	+64	New	+$4.06K	﹤0.01%	1086

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Daiwa Securities Group's ANIP Position: Q1 2026 in Review

Daiwa Securities Group sold out of ANI Pharmaceuticals (ANIP) in Q1 2026, closing a stake of 70 shares — an estimated $6K sold.

Daiwa Securities Group first reported a position in ANIP in Q1 2018 and held it in 28 quarters. The position peaked at $6K in Q4 2025. 281 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

Daiwa Securities Group reported no remaining ANI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 70 ANI Pharmaceuticals shares in Q1 2026, an estimated $6K.
Daiwa Securities Group first reported a position in ANI Pharmaceuticals in Q1 2018 and held it in 28 quarters.
Daiwa Securities Group's ANI Pharmaceuticals position peaked at $6K in Q4 2025.
281 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.